AH
The startup has developed a non-invasive health screening system that utilizes enhanced TRF methods for the rapid analysis of biological samples, enabling early detection of urinary tract, oral, and prostate cancers, as well as gastroenterological and infectious diseases. This technology provides healthcare professionals with accurate and affordable diagnostic tests, improving preventive healthcare outcomes.
Updated 3 months ago
Funding
$8.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup has developed a non-invasive health screening system that utilizes enhanced TRF methods for the rapid analysis of biological samples, enabling early detection of urinary tract, oral, and prostate cancers, as well as gastroenterological and infectious diseases. This technology provides healthcare professionals with accurate and affordable diagnostic tests, improving preventive healthcare outcomes.